Who We Are
Partners & Senior Management
Charles (Hutch) Hutchinson, PhD
Chairman
Hutchinson completed his PhD in electrical engineering at Stanford and has worked for the U.S. Navy, private corporations, and educational institutions. He founded Medical Media Systems, later M2S, Inc., and recruited M. Weston Chapman as CEO in 2000. He was also founder, CEO, and chairman of Glycofi, Inc., which used genetically-engineered yeast to produce human replicated proteins. The company received $30 million in initial investment and six years later was sold to Merck for $400 million. Hutchinson is also dean emeritus of the Thayer School of Engineering at Dartmouth College.
BS Illinois Institute of Technology | PhD Stanford University
M. Weston Chapman
President & CEO
Chapman is an entrepreneur and investor with substantial start-up and corporate turnaround experience. Immediately prior to PCD, he was chairman, president, and CEO of M2S, Inc., where he built and led a team that re-started the company and grew it to an 80% market share, then sold it to affiliates of Pfizer and a private equity firm. Using Lean Six Sigma and ISO 9000, M2S reduced its reject rate from 75% to less than .05%, while reducing marginal cost by 90%.
In 2010 with Charles Hutchinson, Ph.D., Chapman formed PCD Systems to answer the unmet needs of hospitals and physician groups in protocol- and data-controlled quality systems in oncology. He is a Lean Six Sigma Black Belt, is an ASQ Certified Manager of Quality and Organizational Excellence, is an ASQ Certified Quality Auditor, holds many patents, and has done noteworthy work in statistical process control systems. He is on the Advisory Board of the Norris Cotton Cancer Center and is Adjunct Professor at Dartmouth Medical School, specializing in ISO-related medical quality systems.
Additionally, Chapman is a former managing director of investment firms Oppenheimer & Co. and Donaldson, Lufkin & Jenrette, where he led the acquisition, operation, growth financing, and turnaround of companies in North America, South America, and Asia. He was one of the founders of diversified insurer Coventry Corporation, now Coventry Health Care.
AB Dartmouth College | MBA Tuck School of Business
Grant Bagley, MD, JD
Partner
Dr. Bagley has extensive clinical, scientific, regulatory, and legal experience. He practiced clinical medicine from 1965 until 1990 before becoming medical officer in the Office of the Commissioner of the U.S. Food and Drug Administration. He then moved to leadership roles within CMS, serving first as acting director of their Division of Physician Services in the office of Practitioner and Ambulatory Care Policy, and then as director overseeing clinical and scientific determination of Medicare coverage policy and the assessment of new technology.
Dr. Bagley has received many honors and awards in the healthcare field, including an NIH special fellowship in Biophysics and Bioengineering, and a Pew Foundation Fellowship in Health Policy Planning and Analysis from the RAND Corporation.
JD University of Utah | MD George Washington University
John C. Collins, JD, MPH
Partner
From 1975 to 2007, Collins was CEO of the Dartmouth-Hitchcock Clinic, the 750-physician, multi-specialty practice within Dartmouth-Hitchcock Medical Center (DHMC), operating in Lebanon, Manchester, Bedford, Concord, Keene and Nashua, NH. During his tenure he developed a growth strategy built on patient access, quality care, process improvement, and a strengthened academic mission, and led the acquisition of the Matthew Thornton Health Plan, a group and IPA model HMO. He invested DHMC in the Vermont Health Plan, a network model managed care organization, and created the self-insured Dartmouth-Hitchcock professional liability program, which currently provides broad coverage at 50% of the cost of commercial policies.
Collins is assistant professor at Dartmouth Medical School and continues to serve as chair and president of Hamden RRG and Hamden Assurance Company Ltd. (Bermuda), along with other for-profit and nonprofit boards.
BS Cornell University | MPH University of Michigan | JD Georgetown University
Jack Cronenwett, MD
Partner
Dr. Cronenwett is professor of surgery at Dartmouth-Hitchcock Medical Center and served as chair of the Section of Vascular Surgery from 1984 to 2007. His research involves abdominal aortic aneurysms, outcome analysis, and quality improvement in vascular surgery. Since 2002 he has served as medical director of the Vascular Study Group of New England, a regional cooperative quality improvement project of twenty hospitals. He has published over 250 peer-reviewed articles, books, and book chapters and delivered hundreds of scientific presentations.
Cronenwett is past president of the New England Society for Vascular Surgery, the Association of Program Directors in Vascular Surgery, and the Society for Vascular Surgery. He was also a member of the Residency Review Committee for Surgery of the ACGME, and is editor emeritus of the Journal of Vascular Surgery and editor of Rutherford’s Vascular Surgery Textbook, 7th Ed.
BS University of Michigan | MD Stanford University
Steven Maker
VP Technology and Quality Systems
Maker is a technology executive with over 25 years experience leading software design and development teams. An expert in Lean software development and its applications for medical IT, Maker has spent the last two years focused exclusively on problems in medical oncology quality management, metrics, and process design and improvement.
For five years, Maker led the team at Dartmouth-Hitchcock Medical Center that developed the electronic medical record, used by more than 5,000 clinicians. More recently, he was CTO at M2S, Inc., working with M. Weston Chapman. He led the development effort addressing needs in vascular imaging, registries, and clinical trials, and his team shipped 100 software releases in a single calendar year.
Maker earned a Lean Six Sigma Black Belt from the Thayer School of Engineering at Dartmouth, is an ASQ Certified Quality Auditor, Certified Scrum Master, and Kanban practitioner. He completed coursework for the Ph.D. in physics at Dartmouth College, and has served as chair of several nonprofit boards.
BA Carleton College
Mario Martinez
Project Manager, Clinical Systems Analyst
Martinez is a skilled project manager with a strong background in statistics, metrics creation, and process improvement. His special expertise includes Lean process design, quality systems, quality metrics, and operations. He has formal training in industrial engineering and engineering management, focusing on technical project management, operations management, and technology assessment. He is a Lean Six Sigma Green Belt and ISO-certified auditor.
Recently, Martinez coauthored white papers on leading oncology pathways and metrics organizations and patient-reported outcomes. He has been involved in process design for the State of Vermont’s oncology payment reform pilot, and has been instrumental in design of metrics for a client’s CMA.
BS INTEC (Santo Domingo); MEM Thayer School of Engineering
Investors
Borealis Ventures
Borealis Ventures partners with exceptional entrepreneurs to build companies from the earliest stages. They have sector expertise in information technology, life sciences, and internet and mobile services, plus a wide network of industry connections that let them readily support PCD Systems in validating market opportunities, recruiting an expert management team, establishing commercial partnerships, and accelerating business growth.
Contact Us
How can our team help your healthcare management organization? Phone us at 603-727-7300 or email us at moc.sysdcpnull@ofni.
